Determination of anti-COVID-19 IgG and IgM seroprevalence among pregnant women at Pietersburg Hospital, Limpopo Province, South Africa
DOI:
https://doi.org/10.7196/SAMJ.2024.v114i3.702Keywords:
COVID-19, Seroprevalence, pregnant women, ImmunoglobulinAbstract
Background. COVID-19 has been a major public health concern globally, leading to a higher mortality rate, especially among immunosuppressed individuals, who include pregnant women, people with HIV and people living with other comorbidities. Pregnant women are considered to be a special population group owing to their specific susceptibility to some infectious diseases.
Objective. To determine the seroprevalence of anti-SARS-CoV-2 antibodies among pregnant women attending an antenatal clinic. Method. This was a descriptive cross-sectional study that tested blood samples from pregnant women who attended the antenatal clinic from March to July 2022 using the Orient Gene Biotech lateral flow immune-chromatographic assay according to manufacturer instructions. The assay detects IgM and IgG antibodies against SARS-CoV-2.
Results. A total of 2 649 blood samples were tested; 2 039 (77.0%) samples tested positive for IgG, 7 (0.3%) tested positive for IgM, and 100 (3.7%) tested positive for both IgG and IgM. The study found a seroprevalence of 80.7% of IgG.
Conclusion. The study findings showed evidence of acute COVID-19 infection in our patient population despite the consensus that COVID-19 infection is dissipating.
References
Al Mansoori H, Alsaud AB, Yas H. The impact of COVID-19 on increasing the cost of labor and project price in the United Arab Emirates. Artic Int J Pharm Res Sch 2021;13(01):5069-5076. https:// doi.org/10.31838/ijpr/2021.13.01.691
Li H, Cao Y. The bright side of the COVID-19 pandemic: Public coughing weakens the overconfidence bias in non-health domains. Pers Individ Dif 2021;178(2021). https://doi.org/10.1016/j.paid.2021.110861 3. World Health Organization. Coronavirus Disease (COVID-19) Situation Reports. Geneva: WHO, 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (accessed
November 2022).
NICD. National COVID-19 daily report. Pretoria: NICD, 2022. https://www.nicd.ac.za/diseases-a-
z-index/disease-index-covid-19/surveillance-reports/national-covid-19-daily-report/ (accessed 26
November 2022).
Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its impact on patients with COVID-19.
SN Compr Clin Med 2020;2(8):1069-1076. https://doi.org/10.1007/s42399-020-00363-4 https://link.
springer.com/article/10.1007/s42399-020-00363-4 (accessed 26 November 2022).
Salma U. Relationship of COVID-19 with pregnancy. Taiwan J Obstet Gynecol 2021;60(3):405-411.
https://doi.org/10.1016/j.tjog.2021.03.005
Reynolds RM, Stock SJ, Denison FC, Maybin JA, Critchley HOD. Pregnancy and the SARS-COV-2 pandemic. Physiol Rev 2022;102(3):1385-1391. https://doi.org/10.1152/physrev.00003.2022
Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ 2020;370(1):1-17. https://doi.org/10.1136/bmj.m3320
Chmielewska B, Barratt I, Townsend R, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: A systematic review and meta-analysis. Lancet Glob Heal 2021;9(6):759-772. https://doi.org/10.1016/S2214-109X(21)00079-6
Tomaselli V, Ferrara P, Cantone GG, et al. The effect of laboratory-verified smoking on SARS-CoV-2 infection: Results from the Troina sero-epidemiological survey. Intern Emerg Med 2022;17(6):1617- 1630. https://doi.org/10.1007/s11739-022-02975-1
Fairlie L, Sawry S, Patel F, et al. COVID-19 in pregnancy in South Africa: Tracking the epidemic and defining the natural history. S Afr Med J 2020;110(8):729-731. https://doi.org/10.7196/SAMJ.2020. v110i9.15012
Demey B, Daher N, François C, et al. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. J Infect 2020;81(2):6-10. https://doi.org/10.1016/j. jinf.2020.04.033
Lucinde R, Mugo D, Bottomley C, et al. Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals. medRxiv 2021;2021.02.05.21250735. https://doi. org/10.1101/2021.02.05.21250735
Maryan MA, Dahie HA, Hassan NA, et al. Seroprevalence of SARS-CoV-2 virus antibodies and sociodemographic features of pregnant women in Mogadishu, Somalia: A cross-sectional survey study. BMJ Open 2022;12(6):1-11. https://doi:10.1136/bmjopen-2021-059617
Mansuy JM, Kenfack MT, Burel S, et al. High SARS-CoV-2 IgG seroprevalence among pregnant Cameroun women 14 months after the beginning of the pandemic. Public Health 2022;(April 2020):2020-2022. https://doi.org/10.22541/au.164873379.97139041/v1
Sawry L, Le Roux J, Wolter N, et al. High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa. Int J Infect Dis 2022;125:241-249. https://doi.org/10.1016/j.ijid.2022.10.036
Basu JK, Chauke L, Magoro T. Maternal mortality from COVID 19 among South African pregnant women. J Matern Neonatal Med 2021; 35(25):5932-5934. https://doi.org/10.1080/14767058.2021. 1902501
Madhi SA, Kwatra G, Myers JE, et al. Population immunity and COVID-19 severity with omicron variant in South Africa. N Engl J Med 2022;386(14):1314-1326. https:// doi.org/10.1056/NEJMoa2119658
Bingham J, Cable R, Coleman C, et al. Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022. Res Sq 2022. https://doi.org/10.21203/rs.3.rs-1687679/v2
Lewis HC, Ware H, Whelan M, et al. SARS-CoV-2 infection in Africa: A systematic review and meta- analysis of standardised seroprevalence studies, from January 2020 to December 2021. BMJ Glob Heal
;7(8):e008793. https://doi.org/10.1136/bmjgh-2022-008793
Ferdinands JM, Rao S, Dixon BE, et al. Waning 2-dose and 3-dose effectiveness of mRNA
vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalisations among adults during periods of Delta and Omicron variant predominance – VISION network, 10 states, August 2021 - January 2022. Morb Mortal Weekly Rep 2022;71(7):255. https://doi.org/10.15585%2Fmmwr.mm7107e2
Vale AJM, Fernandes ACL, Guzen FP, Pinheiro FI, de Azevedo EP, Cobucci RN. Susceptibility to COVID-19 in pregnancy, labor, and postpartum period: Immune system, vertical transmission, and breastfeeding. Front Glob Women’s Heal 2021;2:8. https://doi.org/10.3389/fgwh.2021.602572
Cervantes O, Cruz Talavera I, Every E, et al. Role of hormones in the pregnancy and sex-specific outcomes to infections with respiratory viruses. Immunol Rev 2022;308(1):123-148. https://doi. org/10.1111/imr.13078
Vizheh M, Muhidin S, Aghajani F, et al. Characteristics and outcomes of COVID-19 pneumonia in pregnancy compared with infected nonpregnant women. Int J Gynecol Obstet 2021;153(3):462-468. https://doi.org/10.1002/ijgo.13697
Mbombi MO, Muthelo L, Mphekgwane P, et al. Prevalence of COVID-19 vaccine hesitancy in a rural setting: A case study of DIMAMO Health and Demographic Surveillance Site, Limpopo Province of South Africa. J Respir 2022;2(2):101-110. https://doi.org/10.3390/jor2020008
Britton T, Ball F, Trapman P. A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2. Science 2020;369(6505):846-849. https://doi.org/10.1126/ science.abc6810
Ghosh D, Jonathan A, Mersha TB. COVID-19 pandemic: The African paradox. J Glob Health 2020;10(2):1-6. https://doi.org/10.7189%2Fjogh.10.020348
Goldblatt D. SARS-CoV-2: From herd immunity to hybrid immunity. Nat Rev Immunol 2022;22(6):333- 334. https://doi.org/10.1038/s41577-022-00725-0
Goel RR, Painter MM, Apostolidis SA, et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science 2021;374(6572). https://www.science.org/doi/10.1126/ science.abm0829 (accessed 27 November 2022).
Seow J, Graham C, Merrick B, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol 2020;5(12):1598-1607. https://doi.org/10.1038/s41564-020-00813-8
Li Z, Yi Y, Luo X, et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol 2020;92(9):1518-1524. https://doi.org/10.1002/ jmv.25727
George JA, Khoza S, Mayne E, et al. Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020. S African Med J 2021;111(11):1078-1083. https://doi.org/10.7196/ SAMJ.2021.v111i11.15669
Downloads
Published
Issue
Section
License
Copyright (c) 2024 I Rukasha, S T S Pheeha, M R Lekalakala, P Malope
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
